MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 199 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.76 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $17,325 | -4.7% | 75 | 0.0% | 0.00% | -25.0% |
| Q1 2023 | $18,170 | -100.0% | 75 | -100.0% | 0.00% | -100.0% |
| Q4 2022 | $87,096,770 | +4237.5% | 300,075 | +1166.1% | 21.01% | +6927.4% |
| Q4 2021 | $2,008,000 | +6.2% | 23,700 | 0.0% | 0.30% | +124.8% |
| Q3 2021 | $1,890,000 | -17.9% | 23,700 | +0.2% | 0.13% | -28.5% |
| Q2 2021 | $2,303,000 | -16.8% | 23,654 | 0.0% | 0.19% | +100.0% |
| Q1 2021 | $2,768,000 | +5.2% | 23,654 | 0.0% | 0.09% | -19.8% |
| Q4 2020 | $2,630,000 | -84.0% | 23,654 | -82.9% | 0.12% | -90.3% |
| Q3 2020 | $16,451,000 | +14.2% | 138,554 | +8.9% | 1.19% | +3.7% |
| Q2 2020 | $14,411,000 | +435.1% | 127,254 | +215.5% | 1.15% | +465.0% |
| Q1 2020 | $2,693,000 | -79.6% | 40,334 | -72.1% | 0.20% | -90.5% |
| Q4 2019 | $13,190,000 | – | 144,770 | – | 2.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |